LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
YSG
Yatsen Holding Limited
There isn't enough reported data to score YSG yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
YSG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
YSG's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
YSG PE Valuation
YSG has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
YSG Forward outlook
There aren't enough analyst estimates for YSG to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
YSG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.33 | +$0.49 |
| Q1 2026 | -$0.21 | +$0.69 |
| Q4 2025 | -$0.13 | +$0.94 |
| Q3 2025 | -$0.74 | +$0.42 |
| Q2 2025 | -$0.82 | +$0.43 |
| Q1 2025 | -$0.90 | +$0.38 |
| Q4 2024 | -$1.07 | +$0.03 |
| Q3 2024 | -$1.16 | -$0.68 |
YSG has the edge over LCID on earnings, with more consistent year-over-year improvement.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over YSG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
YSG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $171.6M | +6.2% |
| Q1 2026 | $153.2M | +23% |
| Q4 2025 | $204.2M | +17% |
| Q3 2025 | $149.1M | +50% |
| Q2 2025 | $161.5M | +35% |
| Q1 2025 | $124.8M | +7% |
| Q4 2024 | $175M | +11% |
| Q3 2024 | $99.4M | -8.5% |
YSG's revenue is recovering but still below its 2020 peak: $172M last quarter, up 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -12% | -6.4 points |
| Q1 2026 | -9.7% | -5.6 points |
| Q4 2025 | -0.9% | -2 points |
| Q3 2025 | -8.4% | +13 points |
| Q2 2025 | -5.1% | +12 points |
| Q1 2025 | -4.1% | +16 points |
| Q4 2024 | 1.1% | +18 points |
| Q3 2024 | -21% | +11 points |
YSG has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has the edge over YSG on cash flow, with more consistent year-over-year improvement.
YSG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$20.8M | -$20.8M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | -100% |
YSG's free cash flow was −$21M over the past year, against $0 the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
YSG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -113K shares |
| 1 year | +1.1% | +983K shares |
| 3 years | -16% | -17.7M shares |
| 5 years | -26% | -32.6M shares |
| Available history | -30% | -41.1M shares |
YSG has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $16.7M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
YSG spent $17M buying back its own shares over the past year, after none the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
YSG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -35.5x | Net Cash |
| Q4 2025 | -7.1x | Net Cash |
| Q1 2020 | 8.5x | High |
| Q4 2019 | -1.9x | Net Cash |
YSG has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
YSG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.3 | Oversold |
| Stochastic | 11.9 | Oversold |
YSG's weekly RSI is 29 (oversold) and its Stochastic is 12 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
YSG PE vs Consumer Cyclical Sector
YSG has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
YSG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.36 | 17% below |
| 20 week MA | $2.85 | 32% below |
| 50 week MA | $3.32 | 41% below |
| 100 week MA | $4.88 | 60% below |
| 200 week MA | $4.68 | 58% below |
YSG is in a downtrend: it's below all five of its weekly moving averages, and 58% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
YSG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $100.2 | $80.0 | -20% |
| 2021 | $80.0 | $9.45 | -88% |
| 2022 | $9.45 | $7.35 | -22% |
| 2023 | $7.35 | $3.66 | -50% |
| 2024 | $3.66 | $4.43 | +21% |
| 2025 | $4.43 | $4.13 | -6.8% |
| 2026 YTD | $4.13 | $1.95 | -53% |
YSG has the edge over LCID on returns for 2026, with the stronger performance.